sLAG-3 in Non-Small-Cell Lung Cancer Patients’ Serum

OncoTargets and Therapy- New Zealand

doi 10.2147/ott.s164178

Full Text

Abstract

Available in

Date

Authors

Publisher

Informa UK Limited

Related search

Prognostic Impact of Serum Transthyretin in Patients With Non‑small Cell Lung Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2019English

3’-Phosphoadenosine 5’-Phosphosulfate Synthase 1 (PAPSS1) Knockdown Sensitizes Non-Small Cell Lung Cancer Cells to DNA Damaging Agents

Oncotarget
Oncology
2015English

Advanced Non-Small Cell Lung Cancer in Elderly Patients

Breathe
PulmonaryRespiratory Medicine
2012English

Non-Small Cell Lung Cancer

English

Chemotherapy for Non-Small Cell Lung Cancer in Elderly Patients

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

Ifosfamide in Patients With Recurrent Non Small Cell Lung Cancer

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
1986English

Expression and Clinical Significance of IGF-1, IGFBP-3, and IGFBP-7 in Serum and Lung Cancer Tissues From Patients With Non-Small Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2013English

Diagnostic Value of Serum miR197 and miR145 in Non‑small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2019English

HER2 Mutations in Chinese Patients With Non-Small Cell Lung Cancer

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy